Sherry Li
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal cell carcinoma treatment 4
- Lung Cancer Treatments and Mutations 3
- Lung Cancer Diagnosis and Treatment 2
- Cystic Fibrosis Research Advances 2
-
- Cancer Genomics and Diagnostics 6
- Co-authors
- Jean‐François Martini (5 shared papers)Ross A. Soo (3 shared papers)Rita Chiari (3 shared papers)Holger Thurm (3 shared papers)Benjamin Besse (3 shared papers)Gregory J. Riely (3 shared papers)Todd M. Bauer (3 shared papers)Benjamin Solomon (3 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Future Oncology (2 papers)Journal of Clinical Oncology (2 papers)Breast Cancer Research and Treatment (1 paper)Blood (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Sherry Li
18 papers receiving 733 citations
Sherry Li's Hit Papers
Peers
Comparison fields: 5 of 68
- Pulmonary and Respiratory Medicine 514
- Oncology 334
- Cancer Research 161
- Molecular Biology 248
- Pathology and Forensic Medicine 57
Countries citing papers authored by Sherry Li
This map shows the geographic impact of Sherry Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Li more than expected).
Fields of papers citing papers by Sherry Li
This network shows the impact of papers produced by Sherry Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Li. The network helps show where Sherry Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Sherry Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 279 | |
| 2 | Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial Hit paper breakdown → | 2019 | 261 |
| 3 | 2014 | 62 | |
| 4 | 2018 | 33 | |
| 5 | 2023 | 23 | |
| 6 | 2012 | 22 | |
| 7 | 2018 | 18 | |
| 8 | Manual of Medical Therapeutics | 1980 | 12 |
| 9 | 2019 | 9 | |
| 10 | 2018 | 7 | |
| 11 | 2004 | 5 | |
| 12 | 2020 | 5 | |
| 13 | 2025 | 4 | |
| 14 | 2018 | 4 | |
| 15 | 2025 | 4 | |
| 16 | 2023 | 3 | |
| 17 | 2025 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2022 | 0 |
About Sherry Li
Sherry Li is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Epidemiology, having authored 19 papers that have together received 757 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Renal cell carcinoma treatment (4 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cystic Fibrosis Research Advances (2 papers), Attachment and Relationship Dynamics (1 paper) and Retinal Imaging and Analysis (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (514 citations), Oncology (334 citations), Cancer Research (161 citations), Molecular Biology (248 citations) and Pathology and Forensic Medicine (57 citations). Sherry Li has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Jean‐François Martini, Ross A. Soo, Rita Chiari, Holger Thurm, Benjamin Besse, Gregory J. Riely, Todd M. Bauer, Benjamin Solomon, Sai‐Hong Ignatius Ou and Jill S. Clancy. Their work appears in journals such as Clinical Cancer Research, Future Oncology, Journal of Clinical Oncology, Breast Cancer Research and Treatment and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.